Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global ...

The Infusion Pump Market represents a critical segment within modern healthcare technology, enabling controlled and accurate ...

New York City Health + Hospitals/South Brooklyn Health unveiled a $2 million expansion of its Oncology and Infusion Center, ...

St. Joseph Medical Center files initial plans to make use of unoccupied space for new infusion suite.

Designed for advanced Parkinson’s with poorly controlled motor fluctuations, the infusion delivers steadier levodopa exposure than pills via continuous subcutaneous dosing.

Aplagon is also planning for 2026 a Phase 2 clinical trial for arteriovenous fistula (AVF) maturation failure in Europe, following the successful completion of its Phase 1 AVF trial. The study ...

A Richmond Hill family is asking for community support to fund a medical treatment at Duke University for their daughter ...

Fort Wayne Rheumatology and Infusion offers a full range of advanced treatment options, including biologic therapies, disease-modifying medications, and on-site infusion services. The practice is ...

For patients facing cancer treatment, every moment in a hospital can feel daunting. On Friday, Feb. 27, NYC Health + Hospitals/South Brooklyn Health opened ...

Subcutaneous delivery provides a markedly shorter administration time than IV infusion, potentially improving adherence and preserving patient functionality in advanced EGFR-mutated NSCLC. Reduced ...

The Phoenix VA Health Care System (PVAHCS) is in the midst of a major construction project that will more than triple its infusion center space.

European Commission approval enables 2 mg/kg Q4W pegunigalsidase alfa for stable, ERT-treated adults, extending infusion intervals from Q2W to Q4W to lessen cumulative treatment burden. Evidence ...